Loading…
CNS Pharmaceuticals, Inc. is projected to rise to $7.53 by 2027, a +30% move from its current price of $5.79. CNSP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $5.47 | $5.78 | $6.12 | -0.09% |
| Aug 6 | $5.34 | $5.78 | $6.25 | -0.18% |
| Aug 7 | $5.24 | $5.77 | $6.36 | -0.28% |
| Aug 8 | $5.16 | $5.77 | $6.45 | -0.37% |
| Aug 9 | $5.09 | $5.76 | $6.53 | -0.46% |
| Aug 10 | $5.03 | $5.76 | $6.60 | -0.55% |
| Aug 11 | $4.97 | $5.75 | $6.66 | -0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.97 | $5.75 | $6.66 | -0.64% |
| Week 2 | $4.64 | $5.72 | $7.04 | -1.28% |
| Week 3 | $4.40 | $5.68 | $7.33 | -1.92% |
| Week 4 | $4.20 | $5.64 | $7.57 | -2.55% |
| Week 5 | $4.03 | $5.61 | $7.79 | -3.18% |
| Week 6 | $3.88 | $5.57 | $7.99 | -3.80% |
| Week 7 | $3.75 | $5.53 | $8.17 | -4.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CNS Pharmaceuticals, Inc. is a clinical pharmaceutical company engaged in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors.
The company was incorporated in 2017 and is headquartered in Houston, Texas.
CNSP is a publicly traded name with a current price of $5.82 and a market cap of $8.5M, ranking 5130. The current price outlook for 2026 shows an average of $5.82, a min of $2.13, a max of $6.59, and a neutral sentiment. The forecast extends beyond 2026, with 2027 at an average of $7.58 (ROI 30.3, sentiment BULLISH) and 2028 at an average of $8.75 (ROI 50.4, sentiment BULLISH).
By 2030, the average is projected to $8.34 (ROI 43.5, sentiment BULLISH), continuing to 2035 with an average of $10.79 (ROI 85.4, sentiment BULLISH). The long-range view shows further upside, with 2040 at an average of $9.68 (ROI 66.5, sentiment BULLISH) and 2050 at an average of $20.28 (ROI 248.7, sentiment BULLISH). The maximums in the forecast reach as high as $46.65 by 2050, underscoring potential upside while acknowledging the uncertainty inherent in these projections.
A major floor 63.2% below — a decisive break under it would weaken the trend.
The nearest floor, 31.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.5% away) — a breakout level to watch.
A major ceiling 35.4% above — clearing it would confirm fresh momentum.
Key CNSP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CNSP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.16 | Buy | $5.30 | Buy |
| MA 10 | $5.31 | Buy | $5.23 | Buy |
| MA 20 | $5.18 | Buy | $5.13 | Buy |
| MA 50 | $4.94 | Buy | $4.89 | Buy |
| MA 100 | $4.14 | Buy | $5.12 | Buy |
| MA 200 | $5.10 | Buy | $148.74 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.46 | Neutral |
| Stoch RSI (14) | 83.62 | Sell |
| CCI (20) | 173.74 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 24.29 | Buy |
| Bollinger %B (20,2) | 1.03 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.36 | Buy |
| Awesome (5,34) | 0.26 | Buy |
| Ultimate (7,14,28) | 54.89 | Neutral |
| Momentum (10) | 0.78 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 5.08 | Buy |
| ADX (14) | 11.29 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture is bullish. The RSI14 sits at 60, and the SMA50 is $4.94 while the SMA200 is $5.10, indicating a near-term positive slope relative to longer-term averages. Immediate support is listed at $3.98 and resistance at $5.82, with a 30-day range of $4.03 to $8.39.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.13 | $5.79 | $6.54 | 0% | Neutral | |
| $5.49 | $7.53 | $11.16 | +30% | Bullish | |
| $5.98 | $8.72 | $13.80 | +51% | Bullish | |
| $4.92 | $7.57 | $12.58 | +31% | Bullish | |
| $5.14 | $8.29 | $14.36 | +43% | Bullish | |
| $4.39 | $7.40 | $13.27 | +28% | Bullish | |
| $3.72 | $6.54 | $12.09 | +13% | Neutral | |
| $4.05 | $7.42 | $14.11 | +28% | Bullish | |
| $4.32 | $8.24 | $16.05 | +42% | Bullish | |
| $5.42 | $10.73 | $21.40 | +85% | Bullish | |
| $4.35 | $9.67 | $21.22 | +67% | Bullish | |
| $9.07 | $20.15 | $46.35 | +248% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.13 | $5.79 | $6.43 | +0.00% |
| September 2026 | $4.21 | $5.11 | $6.48 | -11.70% |
| October 2026 | $4.32 | $5.32 | $6.89 | +4.10% |
| November 2026 | $4.04 | $5.04 | $6.63 | -5.26% |
| December 2026 | $3.89 | $4.90 | $6.54 | -2.81% |
Click any year to see its month-by-month CNSP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CNSP to range from $2.13 to $6.54 through 2026. The $5.79 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The CNSP price prediction for 2027 points to an average of $7.53 (low $5.49, high $11.16) — a potential gain of +30% on today's $5.79. Momentum favours further upside here.
In 2028, CNSP is projected to trade between $5.98 and $13.80, averaging $8.72 — a potential gain of +51% from today's $5.79. That is up +16% on the projected 2027 average. Buyers look set to stay in control over this stretch.
CNS Pharmaceuticals, Inc.'s 2029 outlook centres on $7.57, within a $4.92 to $12.58 range. That is -13% versus the projected 2028 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2030, CNSP could reach as high as $14.36, with a base case around $8.29 and support toward $5.14 — roughly +43% from $5.79. Buyers look set to stay in control over this stretch.
Expect CNSP to range from $4.39 to $13.27 through 2031. The $7.40 average target implies a +28% move from current prices. That is -11% versus the projected 2030 average. Momentum favours further upside here.
The CNSP price prediction for 2032 points to an average of $6.54 (low $3.72, high $12.09) — a potential gain of +13% on today's $5.79. A consolidation phase looks the most probable path here.
In 2033, CNSP is projected to trade between $4.05 and $14.11, averaging $7.42 — a potential gain of +28% from today's $5.79. That is up +14% on the projected 2032 average. Momentum favours further upside here.
CNS Pharmaceuticals, Inc.'s 2034 outlook centres on $8.24, within a $4.32 to $16.05 range. That is up +11% on the projected 2033 average. That marks a +42% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, CNSP could reach as high as $21.40, with a base case around $10.73 and support toward $5.42 — roughly +85% from $5.79. Momentum favours further upside here.
Expect CNSP to range from $4.35 to $21.22 through 2040. The $9.67 average target implies a +67% move from current prices. That is -10% versus the projected 2035 average. Buyers look set to stay in control over this stretch.
The CNSP price prediction for 2050 points to an average of $20.15 (low $9.07, high $46.35) — a potential gain of +248% on today's $5.79. Momentum favours further upside here.
Investing $1,000 in CNSP today (≈ 172.711572 CNSP) could be worth
$3,480.28
+$2,480.28 (+248%) by 2050 · US Dollar
Based on the average projected CNSP price of $20.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CNSPwould be worth at today's price.
$1,000 invested in CNSP on Jul 31, 2025 (≈ 125.313283 CNSP) would be worth
$725.56
-$274.44 (-27.4%) today · 0.73× · US Dollar
Based on a CNSP entry price of $7.98 vs. today's $5.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.23 | $1,107.07 | +10.7% |
| 1 month ago | $4.68 | $1,237.18 | +23.7% |
| 3 months ago | $2.31 | $2,505.41 | +150.5% |
| 6 months ago | $5.41 | $1,070.24 | +7.0% |
| 1 year ago | $7.98 | $725.56 | -27.4% |
| All time (5.0y) ago | $1,548,000 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CNSP forecast.
Our base-case forecast reaches $12.00 around 2050.
Implied market cap at $12.00: $17.54M
The multi-year forecast shows a trajectory of higher averages in the longer term. In 2027 the average is $7.58 with ROI 30.3 and sentiment BULLISH, followed by 2028 at $8.75 with ROI 50.4 and sentiment BULLISH. The 2030 picture is $8.34 on average with ROI 43.5 and sentiment BULLISH, and 2035 is $10.79 on average with ROI 85.4 and sentiment BULLISH.
Looking further, 2040 is $9.68 on average with ROI 66.5 and sentiment BULLISH, and 2050 is $20.28 on average with ROI 248.7 and sentiment BULLISH, with a max forecast of $46.65 in 2050. These figures illustrate a potential long-term upside, but they are estimates and not guarantees, and actual results can vary."
Tap a question to reveal the answer.
2030 average $8.34; min $5.17; max $14.45; ROI 43.5; sentiment BULLISH.
The 2026 forecast shows an average of $5.82 (neutral) with 0 ROI. From 2027 onward, the forecast provides bullish implications and rising averages, with ROIs including 30.3 in 2027, 50.4 in 2028, 30.6 in 2029, 43.5 in 2030, 27.6 in 2031, 12.8 in 2032, 28.4 in 2033, 42.1 in 2034, and 85.4 in 2035, culminating in 2050 with an average of $20.28 and ROI 248.7.
Yes. The 2030 forecast lists a max of $14.45, which includes $10 as a possible outcome, while the 2030 average is $8.34 and the min is $5.17.
$4.03 to $8.39.
Current price is $5.82 and market cap is $8.5M, with a rank of 5130.
CNS Pharmaceuticals, Inc. Community Discussion
0Share your CNS Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.